KyungDong Pharm Co., Ltd. will release ‘Hyalbon Plus Injection’, a treatment for osteoarthritis, in December. ‘Hyalbon Plus Injection’ is a treatment for arthritis using high molecular weight sodium hyaluronic acid and is a hyaluronic acid preparation with a 3-week/1-cycle treatment. ‘Hyalbon Plus Injection’ is a preparation that reduces the number of administrations by using hyaluronic acid with a high molecular weight and high viscoelasticity compared to the existing 5-week/1-cycle treatment preparation. In addition, by using high molecular weight hyaluronic acid, which is most similar to normal joint synovial fluid, it has the effect of increasing the production of endogenous sodium hyaluronate in the body after administration of this agent. ‘Hyalbon Plus Injection’ promotes the production of endogenous hyaluronic acid in the damaged articular cartilage of arthritis patients and provides viscosity and elasticity, thereby reducing joint pain and expanding the range of motion. It is approved for use in patients with moderate to severe osteoarthritis and is a highly safe agent. ‘Hyalbonfloss Injection’ is a product expected to improve the quality of life for patients suffering from joint pain and restricted movement.

  

☆ Product Information ☆

1. Product name: Hyalbon Plus Co., Ltd.

2. Ingredient content: Sodium hyaluronate 10mg per 1ml

3. Efficacy: Treatment of osteoarthritis of the knee joint and periarthritis of the shoulder.

4. Dosage: Usually, adults administer once a week, 1 tube, into the knee joint space or shoulder joint for 3 consecutive weeks, but the number of administrations is appropriate depending on the symptoms.

5. Packaging unit; 2ml/tube × 3 tubes

6. Product code: 648103690

 

※ For other details, please refer to the product manual.